HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bethany Qiang Selected Research

Chromosome Aberrations (Chromosome Abnormalities)

1/2018Targeting BRCA1/2 deficient ovarian cancer with CNDAC-based drug combinations.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bethany Qiang Research Topics

Disease

1Chromosome Aberrations (Chromosome Abnormalities)
01/2018
1Neoplasms (Cancer)
01/2018
1Ovarian Neoplasms (Ovarian Cancer)
01/2018
1Hematologic Neoplasms (Hematological Malignancy)
01/2018

Drug/Important Bio-Agent (IBA)

12'- cyano- 2'- deoxyarabinofuranosylcytosineIBA
01/2018
1sapacitabineIBA
01/2018
1Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2018
1Drug CombinationsIBA
01/2018
1NucleosidesIBA
01/2018
1ProdrugsIBA
01/2018
1Platinum Compounds (Compounds, Platinum)IBA
01/2018
1Taxoids (Taxanes)IBA
01/2018

Therapy/Procedure

1Therapeutics
01/2018